196 related articles for article (PubMed ID: 10518231)
1. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
el Nahal N; Hassan EO; el Houssinie M
Contraception; 1999 Jun; 59(6):369-75. PubMed ID: 10518231
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Hassan EO; el-Nahal N; el-Hussein M
Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
[TBL] [Abstract][Full Text] [Related]
3. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
[TBL] [Abstract][Full Text] [Related]
4. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Koetsawang S
Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
[TBL] [Abstract][Full Text] [Related]
5. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
7. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
8. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Hassan EO; el-Nahal N; el-Hussinie M
Contraception; 1999 Aug; 60(2):87-92. PubMed ID: 10592855
[TBL] [Abstract][Full Text] [Related]
9. Introduction of cyclofem once-a-month injectable contraceptive in Mexico.
Garza-Flores J; Moraks del Olmo A; Fuziwara JL; Figueroa JG; Alonso A; Monroy J; Perez M; Urbina-Fuentes M; Guevara SJ; Cedeno E; Barrios R; Ferman JJ; Medina LM; Velazquez E; Perez-Palacios G
Contraception; 1998 Jul; 58(1):7-12. PubMed ID: 9743890
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
[TBL] [Abstract][Full Text] [Related]
11. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Shulman LP; Oleen-Burkey M; Willke RJ
Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
[TBL] [Abstract][Full Text] [Related]
12. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
[TBL] [Abstract][Full Text] [Related]
13. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
Bahamondes L; Marchi NM; Nakagava HM; de Melo ML; Cristofoletti Mde L; Pellini E; Scozzafave RH; Petta C
Contraception; 1997 Nov; 56(5):301-4. PubMed ID: 9437558
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive introduction and the management of choice: the role of Cyclofem in Indonesia.
Simmons R; Fajans P; Lubis F
Contraception; 1994 May; 49(5):509-25. PubMed ID: 8045135
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
[TBL] [Abstract][Full Text] [Related]
17. Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia.
Lubis F; Fajans P; Simmons R
Contraception; 1994 May; 49(5):527-41. PubMed ID: 8045136
[TBL] [Abstract][Full Text] [Related]
18. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
Cuong DT; My Huong NT
Contraception; 1996 Sep; 54(3):169-79. PubMed ID: 8899259
[TBL] [Abstract][Full Text] [Related]
19. Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
Bahamondes L; LavĂn P; Ojeda G; Petta C; Diaz J; Maradiegue E; Monteiro I
Contraception; 1997 May; 55(5):307-10. PubMed ID: 9220228
[TBL] [Abstract][Full Text] [Related]
20. Once-a-month injectable contraceptives.
d'Arcangues C
World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]